Table 2.
A comparison of previously reported cases of ocular infections caused by S. aurantiacum.
| Author information | Kim et al. (2) | Li et al. (14) | Carnovale et al. (1) | Present study |
|---|---|---|---|---|
| Antifungal | MIC (µg/mL)/the method used for MIC determination | |||
| Amphotericin B | 16 CLSI | NR | 8 CLSI | 2/SENS |
| Fluconazole | — | NR | — | 8/SENS |
| Itraconazole | 16 CLSI | NR | 0.5 CLSI | 0.12/SENS |
| Posaconazole | 2 CLSI | NR | 0.5 CLSI | 0.12/SENS |
| Voriconazole | 1 CLSI | NR | 0.25 CLSI | 0.38/ETEST |
| Isavuconazole | — | NR | 2 CLSI | NR |
| Caspofungin | 8 CLSI | NR | NR | NR |
| Micafungin | 8 CLSI | NR | NR | NR |
| 5-fluorocytosine | NR | NR | NR | >64 SE |
| Patient age, gender | 70 years, woman | 67 years, female | 4 years, female | 80 years, female |
| Predisposing factors | Mild eye injury due to soil exposition | Previous pterygium surgery with conjunctival autograft | Penetrating trauma by kitchen instrument | Lateral tarsorrhaphy of the right eyelids |
| Type of ocular infection | Infectious scleritis with corneal ulcer | Infectious scleritis with vitritis | Post-traumatic endophthalmitis | Keratitis |
| Identification/time to diagnosis | Culture and sequencing of the ITS region and the 26S rRNA gene/12 days | Culture/6 weeks | Culture and sequencing of the β-tubulin gene/15 days | Culture and MALDI-TOF MS/9 days |
| Country/region | Republic of Korea | Australia, Queensland | Argentina | Czech Republic |
| Targeted therapy | Topical voriconazole and amphotericin B, IV voriconazole | Topical + intravitreal + PO voriconazole | Voriconazole | Topical + oral voriconazole |
| Surgical intervention | Evisceration and enucleation | Enucleation | Surgery for corneal trauma | Evisceration |
| Follow-up duration | NR | NR | NR | 3 years |
| Final visual outcome | Loss of eye | Loss of eye | A favorable clinical outcome | Loss of vision |
CLSI, CLSI Standards M38 Reference method for broth dilution antifungal susceptibility testing of filamentous fungi ETEST, E-test, SENS, Sensititre YeastOne, NR, not reported.